111 related articles for article (PubMed ID: 12359657)
21. Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure.
Magrì D; Brioschi M; Banfi C; Schmid JP; Palermo P; Contini M; Apostolo A; Bussotti M; Tremoli E; Sciomer S; Cattadori G; Fiorentini C; Agostoni P
Circ Heart Fail; 2009 May; 2(3):175-80. PubMed ID: 19808337
[TBL] [Abstract][Full Text] [Related]
22. Insulin ameliorates exercise ventilatory efficiency and oxygen uptake in patients with heart failure-type 2 diabetes comorbidity.
Guazzi M; Tumminello G; Matturri M; Guazzi MD
J Am Coll Cardiol; 2003 Sep; 42(6):1044-50. PubMed ID: 13678928
[TBL] [Abstract][Full Text] [Related]
23. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin.
Guazzi M; Marenzi G; Alimento M; Contini M; Agostoni P
Circulation; 1997 Apr; 95(7):1930-6. PubMed ID: 9107182
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
Guazzi M; Melzi G; Marenzi GC; Agostoni P
Clin Pharmacol Ther; 1999 Mar; 65(3):319-27. PubMed ID: 10096264
[TBL] [Abstract][Full Text] [Related]
25. The effect of tiotropium on the pulmonary diffusing capacity.
Gonlugur U
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529
[TBL] [Abstract][Full Text] [Related]
26. Alveolar-capillary membrane diffusion measurement by nitric oxide inhalation in heart failure.
Magini A; Apostolo A; Salvioni E; Italiano G; Veglia F; Agostoni P
Eur J Prev Cardiol; 2015 Feb; 22(2):206-12. PubMed ID: 24165475
[TBL] [Abstract][Full Text] [Related]
27. [Alveolar-capillary dysfunction in heart failure].
De Vita S; Guazzi M; Oreglia J; Guazzi MD
Ital Heart J Suppl; 2002 Oct; 3(10):1022-6. PubMed ID: 12478828
[TBL] [Abstract][Full Text] [Related]
28. Impeded alveolar-capillary gas transfer with saline infusion in heart failure.
Guazzi M; Agostoni P; Bussotti M; Guazzi MD
Hypertension; 1999 Dec; 34(6):1202-7. PubMed ID: 10601119
[TBL] [Abstract][Full Text] [Related]
29. The effect of conductive ventilation heterogeneity on diffusing capacity measurement.
Verbanck S; Schuermans D; Van Malderen S; Vincken W; Thompson B
J Appl Physiol (1985); 2008 Apr; 104(4):1094-100. PubMed ID: 18276899
[TBL] [Abstract][Full Text] [Related]
30. Impact of medical treatment on lung diffusion capacity in elderly patients with heart failure. Baseline characteristics and 1-year follow up after medical treatment.
Petersen CL; Kjaer A
Int J Cardiol; 2005 Feb; 98(3):453-7. PubMed ID: 15708179
[TBL] [Abstract][Full Text] [Related]
31. Pattern of diffusion disturbance related to clinical diagnosis: The K(CO) has no diagnostic value next to the DL(CO).
van der Lee I; Zanen P; van den Bosch JM; Lammers JW
Respir Med; 2006 Jan; 100(1):101-9. PubMed ID: 15946833
[TBL] [Abstract][Full Text] [Related]
32. The components of the carbon monoxide diffusing capacity in man dependent on alveolar volume.
Stam H; Versprille A; Bogaard JM
Bull Eur Physiopathol Respir; 1983; 19(1):17-22. PubMed ID: 6850142
[TBL] [Abstract][Full Text] [Related]
33. Effect of non-insulin-dependent diabetes mellitus on pulmonary function and exercise tolerance in chronic congestive heart failure.
Guazzi M; Brambilla R; Pontone G; Agostoni P; Guazzi MD
Am J Cardiol; 2002 Jan; 89(2):191-7. PubMed ID: 11792341
[TBL] [Abstract][Full Text] [Related]
34. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications.
Cerfolio RJ; Talati A; Bryant AS
Ann Thorac Surg; 2009 Sep; 88(3):930-5; discussion 935-6. PubMed ID: 19699923
[TBL] [Abstract][Full Text] [Related]
35. Week to week variability of pulmonary capillary blood volume and alveolar membrane diffusing capacity in patients with heart failure.
Magini A; Zavorsky GS; Apostolo A; Contini M; Barbieri S; Agostoni P
Respir Physiol Neurobiol; 2021 Aug; 290():103679. PubMed ID: 33962028
[TBL] [Abstract][Full Text] [Related]
36. Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure.
Agostoni P; Cattadori G; Guazzi M; Palermo P; Bussotti M; Marenzi G
Am Heart J; 2000 Nov; 140(5):e24. PubMed ID: 11054632
[TBL] [Abstract][Full Text] [Related]
37. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group.
Amato L; Paolisso G; Cacciatore F; Ferrara N; Ferrara P; Canonico S; Varricchio M; Rengo F
Diabetes Metab; 1997 Jun; 23(3):213-8. PubMed ID: 9233998
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary diffusing capacity at reduced alveolar volumes in children.
Stam H; van den Beek A; Grünberg K; Stijnen T; Tiddens HA; Versprille A
Pediatr Pulmonol; 1996 Feb; 21(2):84-9. PubMed ID: 8882211
[TBL] [Abstract][Full Text] [Related]
39. Diffusing capacity for nitric oxide: reference values and dependence on alveolar volume.
van der Lee I; Zanen P; Stigter N; van den Bosch JM; Lammers JW
Respir Med; 2007 Jul; 101(7):1579-84. PubMed ID: 17229562
[TBL] [Abstract][Full Text] [Related]
40. Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability?
Carvalho SR; Alvarenga Filho H; Papais-Alvarenga RM; Chacur FH; Dias RM
Respirology; 2012 Jul; 17(5):869-75. PubMed ID: 22564062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
